Rocket Pharmaceuticals Inc (RCKT) Insider Trading
- $57,682,934.00
- $46,096,436.21
- April 22, 2024
- John Militello
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 22, 2024 | Insider | 833 | $22.87 | Sell | $19,050.71 | |
| April 15, 2024 | Director | 10,000 | $24.05 | Sell | $240,500.00 | |
| April 12, 2024 | Director | 70,000 | $24.36 | Sell | $1,705,200.00 | |
| April 8, 2024 | Insider | 12,532 | $24.64 | Sell | $308,788.48 | |
| March 21, 2024 | Insider | 2,490 | $28.10 | Sell | $69,969.00 | |
| March 21, 2024 | Director | 274,000 | $28.43 | Sell | $7,789,820.00 | |
| Feb. 29, 2024 | Insider | 10,000 | $29.84 | Sell | $298,400.00 | |
| Feb. 29, 2024 | General Counsel | 4,100 | $29.33 | Sell | $120,253.00 | |
| Feb. 16, 2024 | General Counsel | 3,576 | $29.84 | Sell | $106,707.84 | |
| Feb. 16, 2024 | CEO | 20,272 | $29.84 | Sell | $604,916.48 | |
| Feb. 16, 2024 | Insider | 7,132 | $29.84 | Sell | $212,818.88 | |
| Jan. 22, 2024 | Insider | 638 | $27.20 | Sell | $17,353.60 | |
| Nov. 15, 2023 | Director | 20,000 | $22.53 | Sell | $450,600.00 | |
| Oct. 20, 2023 | Insider | 564 | $17.06 | Sell | $9,621.84 | |
| Sept. 28, 2023 | Director | 10,312 | $21.03 | Sell | $216,861.36 | |
| Aug. 17, 2023 | CEO | 4,767 | $15.47 | Sell | $73,745.49 | |
| Aug. 17, 2023 | Insider | 1,534 | $15.47 | Sell | $23,730.98 | |
| July 20, 2023 | Insider | 573 | $19.03 | Sell | $10,904.19 | |
| April 21, 2023 | Insider | 2,342 | $18.65 | Sell | $43,678.30 | |
| Feb. 17, 2023 | Insider | 3,557 | $19.06 | Sell | $67,796.42 | |
| Feb. 17, 2023 | CEO | 12,194 | $19.06 | Sell | $232,417.64 | |
| Oct. 6, 2022 | Director | 1,355,932 | $14.75 | Buy | $19,999,997.00 | |
| March 30, 2022 | Insider | 45,000 | $16.41 | Sell | $738,450.00 | |
| Feb. 7, 2022 | CEO | 22,000 | $17.34 | Buy | $381,480.00 | |
| May 11, 2021 | Director | 725,000 | $40.03 | Sell | $29,021,750.00 | |
| Dec. 28, 2020 | COO | 16,761 | $56.72 | Sell | $950,683.92 | |
| Dec. 10, 2020 | Director | 247,720 | $56.00 | Buy | $13,872,320.00 | |
| March 18, 2020 | COO | 1,000 | $9.50 | Buy | $9,500.00 | |
| Dec. 10, 2019 | Director | 225,000 | $22.25 | Buy | $5,006,250.00 | |
| April 16, 2019 | Director | 550,005 | $17.50 | Buy | $9,625,087.50 | |
| March 5, 2019 | Insider | 74,900 | $17.17 | Sell | $1,286,033.00 | |
| Dec. 13, 2018 | Director | 38,768 | $15.19 | Sell | $588,885.92 | |
| Dec. 7, 2018 | Director | 57,732 | $15.13 | Sell | $873,485.16 | |
| Dec. 6, 2018 | COO | 5,675 | $14.98 | Buy | $85,011.50 | |
| Aug. 1, 2018 | Director | 637 | $22.00 | Sell | $14,014.00 | |
| Jan. 6, 2017 | Insider | 60,000 | $1.75 | Buy | $105,000.00 | |
| May 13, 2016 | Director | 10,000 | $9.03 | Buy | $90,300.00 | |
| Feb. 23, 2015 | Director | 603,832 | $6.00 | Buy | $3,622,992.00 | |
| Feb. 23, 2015 | Major Shareholder | 814,166 | $6.00 | Buy | $4,884,996.00 |
Insiders are both buying and selling Rocket Pharmaceuticals Inc stock.
The insider traders at Rocket Pharmaceuticals Inc are: John Militello, Rtw Investments, Lp, Gaurav Shah, Kinnari Patel, David P Southwell, Gotham Makker, Jonathan David Schwartz, Martin Wilson, J Martin Carroll, Mark Andrew White, David P. Southwell, Naveen Yalamanchi, Park Bioventures Lp Devon, and Argeris N Karabelas
The most active insider trader at Rocket Pharmaceuticals Inc is John Militello with 7 trades.
Rtw Investments, Lp has sold the most Rocket Pharmaceuticals Inc stock with a total value of $58,043,500.00.
Rtw Investments, Lp has bought the most Rocket Pharmaceuticals Inc stock with a total value of $68,503,651.50.
The most recent insider trade for Rocket Pharmaceuticals Inc was on April 22, 2024.
The single biggest insider buy for Rocket Pharmaceuticals Inc was from Rtw Investments, Lp with a total value of $19,999,997.00 on Oct. 6, 2022.
The single biggest insider sell for Rocket Pharmaceuticals Inc was from Rtw Investments, Lp with a total value of $29,021,750.00 on May 11, 2021.